Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
823
datasets available to search
ShareScore release 0.9.0
Dataset results
823 results for “kRas”
a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors
ClinicalTrials.gov study NCT06166836. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer
ClinicalTrials.gov study NCT04965818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1%
ClinicalTrials.gov study NCT05445843. IPD Sharing: YES. Countries: 19. Publications: 0.
Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02008383. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
ClinicalTrials.gov study NCT04111458. IPD Sharing: YES. Countries: 3. Publications: 0.
Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
ClinicalTrials.gov study NCT01715441. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
ClinicalTrials.gov study NCT01859026. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).
ClinicalTrials.gov study NCT02296203. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ClinicalTrials.gov study NCT06040541. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations
ClinicalTrials.gov study NCT05848843. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe
ClinicalTrials.gov study NCT01791361. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
ClinicalTrials.gov study NCT04916236. IPD Sharing: NO. Countries: 1. Publications: 2.
A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
ClinicalTrials.gov study NCT07174908. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation
ClinicalTrials.gov study NCT04625270. IPD Sharing: NO. Countries: 7. Publications: 2.
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
ClinicalTrials.gov study NCT06917079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)
ClinicalTrials.gov study NCT00788957. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01951690. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of GFH925 in Patients With Advanced Solid Tumors With KRAS G12C Mutations
ClinicalTrials.gov study NCT05005234. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
ClinicalTrials.gov study NCT05288205. IPD Sharing: NO. Countries: 1. Publications: 2.
KRAS Wild-type Metastatic Colorectal Cancer Trial
ClinicalTrials.gov study NCT00879385. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.